time: approximately 70 minutes
Biochemist T. Michael Dexter said “mapping the human genome has been compared with putting a man on the moon, but I believe it is more than that. It is the outstanding achievement not only of our lifetime but in terms of human history.”
Genomics and innovation-related discussions are heating up with the Congressional 21st Century Cures Initiative and the recent White House announcement of the $215 million Precision Medicine Initiative. Join us for a lively discussion, moderated by Ticia Gerber, HL7’s Director of Global Partnerships and Policy, about the role genomics plays in the new frontier of precision medicine. HL7 Clinical Genomics Work Group expert Grant Wood shares current HL7 work in the area of HIT standards products, family health history, genetic test result reporting and precision medicine. Grant Wood is Senior Information Technology Strategist at Intermountain Healthcare and is actively involved with the Institute of Health and the Global Alliance for Genomics and Health.
Webinar discussions and debates address both domestic and international flashpoints around the core issues of interoperability, genetic information, ethical issues and patient care breakthroughs.
- David Shaywitz, MD, PhD, physician-scientist+management consultant; Chief Medical Officer, DNAnexus; Forbes Contributor on entrepreneurial innovation in medicine; Adjunct Scholar, American Enterprise InstituteChief Medical Officer, DNAnexus
- Jessie Tenenbaum, PhD, Associate Director for Bioinformatics, Duke Translational Medicine Institute; Chair, AMIA Genomics and Translational Bioinformatics Working Group
- Grant Wood, Senior Information Technology Strategist at Intermountain Healthcare and HL7 Clinical Genomics Work Group Facilitator